NanoenTekInc (039860) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NanoenTekInc (039860) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.26 Billion ≈ $1.53 Million USD) by net assets (₩73.19 Billion ≈ $49.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is NanoenTekInc's balance sheet to measure how much of total assets are equity-financed.
NanoenTekInc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how NanoenTekInc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 039860 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
NanoenTekInc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NanoenTekInc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CKM Building Material
TWO:8930
|
0.054x |
|
PJBumi Bhd
KLSE:7163
|
0.160x |
|
Midsummer AB (publ)
ST:MIDS
|
-0.108x |
|
Mastech Holdings Inc
NYSE MKT:MHH
|
0.074x |
|
Dong Yang Pipe
KO:008970
|
-0.111x |
|
Orbitech Co. Ltd
KQ:046120
|
-0.069x |
|
Münchener Tierpark Hellabrunn AG
MU:MTP
|
N/A |
|
P.A. Resources Bhd
KLSE:7225
|
-0.020x |
Annual Cash Flow Conversion Efficiency for NanoenTekInc (2013–2024)
The table below shows the annual cash flow conversion efficiency of NanoenTekInc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see how much is NanoenTekInc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩73.99 Billion ≈ $50.15 Million |
₩-2.46 Billion ≈ $-1.67 Million |
-0.033x | -175.79% |
| 2023-12-31 | ₩53.59 Billion ≈ $36.32 Million |
₩-645.79 Million ≈ $-437.64K |
-0.012x | -108.64% |
| 2022-12-31 | ₩57.65 Billion ≈ $39.07 Million |
₩8.04 Billion ≈ $5.45 Million |
0.140x | -21.38% |
| 2021-12-31 | ₩52.34 Billion ≈ $35.47 Million |
₩9.29 Billion ≈ $6.30 Million |
0.177x | +41.71% |
| 2020-12-31 | ₩45.49 Billion ≈ $30.83 Million |
₩5.70 Billion ≈ $3.86 Million |
0.125x | +25.86% |
| 2019-12-31 | ₩41.03 Billion ≈ $27.80 Million |
₩4.08 Billion ≈ $2.77 Million |
0.100x | +131.90% |
| 2018-12-31 | ₩35.15 Billion ≈ $23.82 Million |
₩1.51 Billion ≈ $1.02 Million |
0.043x | -40.33% |
| 2017-12-31 | ₩23.73 Billion ≈ $16.08 Million |
₩1.71 Billion ≈ $1.16 Million |
0.072x | +160.86% |
| 2016-12-31 | ₩25.58 Billion ≈ $17.33 Million |
₩-3.02 Billion ≈ $-2.05 Million |
-0.118x | -28.30% |
| 2015-12-31 | ₩38.41 Billion ≈ $26.03 Million |
₩-3.54 Billion ≈ $-2.40 Million |
-0.092x | -100.69% |
| 2014-12-31 | ₩35.50 Billion ≈ $24.06 Million |
₩-1.63 Billion ≈ $-1.10 Million |
-0.046x | -152.33% |
| 2013-12-31 | ₩23.58 Billion ≈ $15.98 Million |
₩2.07 Billion ≈ $1.40 Million |
0.088x | -- |
About NanoenTekInc
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a resid… Read more